Literature DB >> 828907

Scanning electron microscopy of in vitro chemically transformed mouse embryo cells.

L E Malick, R Langenbach.   

Abstract

A cloned nontumorigenic control cell line of C3H mouse embryo cells (C3H/1OT1/2CL8) and two cell lines derived from it by treatment in vitro with 7,12-dimethylbenz(a)anthracene (DMBA) or 3-methylcholanthrene (MCA) were studied by scanning electron microscopy. Confluent control cells were polygonal in shape and extensively flattened with smooth surfaces. Both in vitro transformants were pleomorphic to fusiform in shape, thicker than the control cells, and lacked contact inhibition. Microvilli of variable length and small marginal ruffles were characteristic surface alterations of the MCA-transformed cells, while blebs and numerous cytoplasmic strands extending between cells were typical of the DMBA transformant. Inoculation of the DMBA-transformed cells into C3H mice and re-establishment of cells from one of the subsequent fibrosarcomas in culture revealed an increased number of microvilli on the surface of the cells and an alteration in growth pattern. Other surface characteristics remained the same. A possible relationship between surface topography and outer membrane glycolipids is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 828907      PMCID: PMC2109669          DOI: 10.1083/jcb.68.3.654

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  30 in total

1.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division.

Authors:  C A Reznikoff; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

Review 2.  Membrane components and enzymes in virally transformed cells.

Authors:  R O Brady; P H Fishman; P T Mora
Journal:  Fed Proc       Date:  1973-01

Review 3.  Cell surface contributions to the malignant process.

Authors:  M S Nachbar; J D Oppenheim; F Aull
Journal:  Am J Med Sci       Date:  1974-09       Impact factor: 2.378

Review 4.  Changes in growth control and growth requirements associated with neoplastic transformation in vitro.

Authors:  D Paul; M Henahan; S Walter
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

5.  A unifying hypothesis concerning the nature of malignant growth.

Authors:  R W Holley
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

6.  Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells.

Authors:  S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

7.  Contact-inhibited revertant cell lines isolated from SV 40-transformed cells. IV. Microfilament distribution and cell shape in untransformed, transformed, and revertant Balb-c 3T3 cells.

Authors:  N S McNutt; L A Culp; P H Black
Journal:  J Cell Biol       Date:  1973-02       Impact factor: 10.539

8.  A scanning electron microscope study of surface features of viral and spontaneous transformants of mouse Balb-3T3 cells.

Authors:  K R Porter; G J Todaro; V Fonte
Journal:  J Cell Biol       Date:  1973-12       Impact factor: 10.539

9.  Contact-inhibited revertant cell lines isolated from SV40-transformed cells. II. Ultrastructural study.

Authors:  N S McNutt; L A Culp; P H Black
Journal:  J Cell Biol       Date:  1971-09       Impact factor: 10.539

10.  Growth of normal and transformed rat embryo fibroblasts: effects of glycolipids from Salmonella minnesota R mutants.

Authors:  C Brailovsky; M Trudel; R Lallier; V N Nigam
Journal:  J Cell Biol       Date:  1973-04       Impact factor: 10.539

View more
  9 in total

1.  Surface morphology of normal and neoplastic rat cells.

Authors:  M W Cloyd; D D Bigner
Journal:  Am J Pathol       Date:  1977-07       Impact factor: 4.307

2.  Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis.

Authors:  Riccardo Alessandro; Maria Antonietta Di Bella; Anna Maria Flugy; Simona Fontana; Francesca Damiani; Chiara Corrado; Paolo Colomba; Matilde Todaro; Domenica Russo; Alessandra Santoro; Elise C Kohn; Giacomo De Leo
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

3.  Cytochalasin D and cationized ferritin as probes for the morphological investigation of blebbing in two human cell lines.

Authors:  W D Meek; W L Davis
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

4.  Congenital murine polycystic kidney disease. I. The ontogeny of tubular cyst formation.

Authors:  E D Avner; F E Studnicki; M C Young; W E Sweeney; N P Piesco; D Ellis; G H Fettermann
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

5.  Actin content and organization in normal and transformed cells in culture.

Authors:  R W Rubin; R H Warren; D S Lukeman; E Clements
Journal:  J Cell Biol       Date:  1978-07       Impact factor: 10.539

6.  An agent or agents produced by virus-transformed cells cause unregulated ruffling in untransformed cells.

Authors:  S E Myrdal; N Auersperg
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

7.  Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alpha.

Authors:  S E Myrdal; D R Twardzik; N Auersperg
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

8.  Changes in surface morphology associated with ageing and carcinogen treatment of Chinese hamster lung cells.

Authors:  C J Harrison; J R Connell; T D Allen; C H Ockey
Journal:  Br J Cancer       Date:  1980-07       Impact factor: 7.640

9.  Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells.

Authors:  J Ren; J Hamada; F Okada; N Takeichi; K Morikawa; M Hosokawa; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1990-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.